Abstract
Background & Objective: Clinical depression is an unsatisfactory mood disorder affecting millions of people worldwide. The disorder is associated with a phenomenal number of suicidal attempts each year, and it has been estimated that 10-20 million people around the world made an attempt of suicide in some stage of the disease. Thus, medicinal intervention is ultimately required to avoid such type of extreme outcomes. There are numerous therapeutic antidepressant options in clinical practice, however, most of them face the challenge of efficacy, side effects, and patient compliance. In this scenario, new effective and safe therapeutic agents are becoming the major focus of researchers in the area of neuropharmacology, who and are evaluating different sources such as synthetic and natural therapeutics. Similarly, thousands of peptides have already shown vital role in human physiology for regulation of different activities.
Conclusion: This mini-review will focus on peptides with reported antidepressant activity, along with their mechanism of action. Furthermore, the present article summarizes the literature pertaining to these peptides as antidepressant agents.
Keywords: Antidepressant potential, future prospects, limitations, mechanism, peptides, therapeutic.
CNS & Neurological Disorders - Drug Targets
Title:Antidepressant Potential of Peptides: New Insights as Future Therapeutic
Volume: 17 Issue: 1
Author(s): Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal
Affiliation:
- Department of Pharmacy, Abdul Wali Khan University, Mardan, 23200,Pakistan
Keywords: Antidepressant potential, future prospects, limitations, mechanism, peptides, therapeutic.
Abstract: Background & Objective: Clinical depression is an unsatisfactory mood disorder affecting millions of people worldwide. The disorder is associated with a phenomenal number of suicidal attempts each year, and it has been estimated that 10-20 million people around the world made an attempt of suicide in some stage of the disease. Thus, medicinal intervention is ultimately required to avoid such type of extreme outcomes. There are numerous therapeutic antidepressant options in clinical practice, however, most of them face the challenge of efficacy, side effects, and patient compliance. In this scenario, new effective and safe therapeutic agents are becoming the major focus of researchers in the area of neuropharmacology, who and are evaluating different sources such as synthetic and natural therapeutics. Similarly, thousands of peptides have already shown vital role in human physiology for regulation of different activities.
Conclusion: This mini-review will focus on peptides with reported antidepressant activity, along with their mechanism of action. Furthermore, the present article summarizes the literature pertaining to these peptides as antidepressant agents.
Export Options
About this article
Cite this article as:
Khan Haroon *, Khattak Sumaira , Mubarak S. Mohammad, Bawazeer S. Saud , Abu-Izneid Tareq and Kamal A. Mohammad , Antidepressant Potential of Peptides: New Insights as Future Therapeutic, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/1871527316666170731102237
DOI https://dx.doi.org/10.2174/1871527316666170731102237 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Inflammatory and Anti-Allergy Drugs in Rhinosinusitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets The GH/IGF-1 Axis and Heart Failure
Current Cardiology Reviews Age-Dependent Changes of the temporal Order - Causes and Treatment
Current Aging Science IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety
CNS & Neurological Disorders - Drug Targets Melatonin Effects on Plasmodium Life Cycle: New Avenues for Therapeutic Approach
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Role of Chromogranins and Other Statins in Homeostasis: An Explanation of the Precise Regulation of Glucose and Ionised Calcium in the Blood; An Overview
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Brainstem Neuropeptides and Vagal Protection of the Gastric Mucosal Against Injury: Role of Prostaglandins, Nitric Oxide and Calcitonin-Gene Related Peptide in Capsaicin Afferents
Current Medicinal Chemistry Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque.
Current Molecular Medicine Olfactory Ensheathing Cells Protect Cortical Neuron Cultures Exposed to Hypoxia
CNS & Neurological Disorders - Drug Targets Subject Index to Volume 10
Current Pharmaceutical Design Pharmacotherapy in Pedatric PTSD: A Developmentally-Focused Review of the Evidence
Current Psychopharmacology Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes
Current Vascular Pharmacology Role of Central and Peripheral CRH in Skin
Current Molecular Pharmacology Anorexia of Aging
Current Nutrition & Food Science Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players
Current Topics in Medicinal Chemistry 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry Bisphenol A as a Factor in the Mosaic of Autoimmunity
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Growth Factors in Arthritis: A Rational for Restoring the IGF-I Response in Chondrocytes
Current Rheumatology Reviews Stress and the α7 Nicotinic Acetylcholine Receptor
Current Drug Targets